What is Chartspan Medical Technologies?
Chartspan Medical Technologies operates as the premier provider of Chronic Care Management (CCM) services in the United States. The company specializes in delivering comprehensive, value-based care solutions that bridge the gap between clinical providers and patients managing complex health conditions. By integrating sophisticated software platforms with clinical support, Chartspan enables healthcare organizations to improve patient engagement, streamline care coordination, and optimize reimbursement structures. Their market position is defined by a commitment to evidence-based interventions that reduce hospital readmissions and enhance the overall quality of life for patients with multiple chronic illnesses.
How much funding has Chartspan Medical Technologies raised?
Chartspan Medical Technologies has raised a total of $88.6M across 8 funding rounds:
Angel/Seed
$1M
Private Equity
$1.7M
Private Equity
$3.2M
Private Equity
$16M
Series A
$15M
Debt
$1M
Private Equity
$50.5M
Angel/Seed (2014): $1M led by Don Byrne
Private Equity (2015): $1.7M supported by Don Byrne
Private Equity (2016): $3.2M, investors not publicly disclosed
Private Equity (2017): $16M backed by Cypress Growth Capital
Series A (2019): $15M, investors not publicly disclosed
Debt (2020): $1M led by PPP
Private Equity (2026): $50.5M, investors not publicly disclosed
Key Investors in Chartspan Medical Technologies
Cypress Growth Capital
Cypress Growth Capital specializes in providing royalty-based funding, offering flexible and non-dilutive growth capital tailored for emerging companies, particularly in the SaaS and tech-enabled services sectors.
Don Byrne
An early-stage investor and strategic partner who has provided consistent financial backing to support the company's foundational growth and initial market entry.
PPP
Public-Private Partnership
What's next for Chartspan Medical Technologies?
With the successful closure of this major enterprise-level funding round, Chartspan Medical Technologies is well-positioned to accelerate its national expansion and technological innovation. The strategic deployment of these funds will likely focus on enhancing the company's proprietary care management software, expanding its clinical workforce to meet rising demand, and deepening its integration with existing electronic health record systems. As the healthcare industry continues its shift toward value-based reimbursement models, Chartspan is poised to capture additional market share by providing the infrastructure necessary for providers to succeed in a performance-driven landscape. The company's growth trajectory suggests a continued focus on operational excellence and the scaling of its service delivery model to reach a broader patient demographic across the country.
See full Chartspan Medical Technologies company page
